Search Orphan Drug Designations and Approvals
-
Generic Name: | oblimersen |
---|---|
Date Designated: | 07/31/2000 |
Orphan Designation: | Treatment of advanced malignant melanoma (Stages II,III, IV). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Genta, Inc. 200 Connell Drive Berkeley Heights, New Jersey 07922 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-